Sangamo enters into asset sale agreements with Lilly and Astellas

Additional information about the Chapter 11 reorganization and asset sales is available through Sangamo's noticing agent at https://www.veritaglobal.net/SangamoTherapeutics.

Patient Stories

Fabry Disease Stories


Hemophilia A Stories


Prion Stories


Renal Transplant Stories